NO992339L - Farmasöytiske formuleringer - Google Patents

Farmasöytiske formuleringer

Info

Publication number
NO992339L
NO992339L NO992339A NO992339A NO992339L NO 992339 L NO992339 L NO 992339L NO 992339 A NO992339 A NO 992339A NO 992339 A NO992339 A NO 992339A NO 992339 L NO992339 L NO 992339L
Authority
NO
Norway
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
NO992339A
Other languages
English (en)
Norwegian (no)
Other versions
NO992339D0 (no
Inventor
Cristi Bell-Huff
Thomas Francis Dolan
Angela Carol Gatlin Hausberger
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO992339D0 publication Critical patent/NO992339D0/no
Publication of NO992339L publication Critical patent/NO992339L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silicon Polymers (AREA)
NO992339A 1998-05-15 1999-05-14 Farmasöytiske formuleringer NO992339L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8564698P 1998-05-15 1998-05-15

Publications (2)

Publication Number Publication Date
NO992339D0 NO992339D0 (no) 1999-05-14
NO992339L true NO992339L (no) 1999-11-16

Family

ID=22193027

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992339A NO992339L (no) 1998-05-15 1999-05-14 Farmasöytiske formuleringer

Country Status (32)

Country Link
US (1) US20020002172A1 (fr)
EP (1) EP0960621A3 (fr)
JP (1) JPH11349483A (fr)
KR (1) KR19990088249A (fr)
CN (1) CN1251758A (fr)
AP (1) AP9901534A0 (fr)
AR (1) AR016481A1 (fr)
AU (1) AU753478B2 (fr)
BG (1) BG103396A (fr)
BR (1) BR9902086A (fr)
CA (1) CA2272042A1 (fr)
CO (1) CO5060503A1 (fr)
DZ (1) DZ2786A1 (fr)
EA (1) EA002830B1 (fr)
GT (1) GT199900061A (fr)
HN (1) HN1999000066A (fr)
HR (1) HRP990144A2 (fr)
HU (1) HUP9901606A2 (fr)
ID (1) ID23299A (fr)
IS (1) IS5046A (fr)
MA (1) MA26629A1 (fr)
NO (1) NO992339L (fr)
NZ (1) NZ335772A (fr)
OA (1) OA11040A (fr)
PA (1) PA8472901A1 (fr)
PE (1) PE20000546A1 (fr)
PL (1) PL333118A1 (fr)
SG (1) SG79255A1 (fr)
SK (1) SK61599A3 (fr)
TR (1) TR199901077A2 (fr)
YU (1) YU21999A (fr)
ZA (1) ZA993338B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2346350C (fr) * 1998-10-05 2008-01-08 Eisai Co., Ltd. Comprimes se delitant rapidement dans la cavite buccale
AU3724400A (en) * 1999-03-08 2000-09-28 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
EP1171134A4 (fr) * 1999-03-16 2005-01-05 Pentech Pharmaceuticals Inc Liberation controlee de sildenafil administre par voie sublinguale ou orale
AU3574500A (en) * 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
ES2381862T3 (es) 2000-09-06 2012-06-01 Mitsubishi Tanabe Pharma Corporation Preparaciones para administración por vía oral
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
IN192750B (fr) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (fr) * 2001-01-26 2002-07-31 Pfizer Products Inc. Formulation pharmaceutique présentant des propriétés de cohesion et de compressibilité améliorées
AU2002314044B2 (en) * 2001-05-09 2006-09-21 Bayer Healthcare Ag Novel use of 2-phenyl-substituted imidazotriazinones
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
WO2003028706A1 (fr) * 2001-09-28 2003-04-10 Sanwa Kagaku Kenkyusho Co.,Ltd Double comprime a desintegration rapide
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
US20050042177A1 (en) * 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
WO2006016530A1 (fr) * 2004-08-10 2006-02-16 Translational Research, Ltd. Composition transnasale dont l’action est immédiate et l’absorbabilité est élevée
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
JP2008546786A (ja) * 2005-06-23 2008-12-25 シェーリング コーポレイション Ｐｄｅ５インヒビターの迅速吸収性経口処方物
CA2623657A1 (fr) * 2005-09-29 2007-04-12 Bayer Healthcare Ag Inhibiteurs pde et combinaisons de ceux-ci pour traiter des troubles urinaires
ES2652415T3 (es) * 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
US20080261991A1 (en) * 2007-02-12 2008-10-23 Dmi Biosciences, Inc. Reducing Side Effects of Tramadol
JP2010532319A (ja) * 2007-06-13 2010-10-07 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 聴覚障害の処置用のｐｄｅ阻害剤
FR2932682B1 (fr) * 2008-06-23 2013-07-12 Bionetwork Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.
AU2010223105B2 (en) 2009-03-09 2016-05-12 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US8827946B2 (en) * 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2011030351A2 (fr) 2009-09-03 2011-03-17 Rubicon Research Private Limited Compositions pharmaceutiques au goût masqué
EP2338474A1 (fr) * 2009-12-23 2011-06-29 Ratiopharm GmbH Comprimé orodispersible contenant une base de sidénafil compactée
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
MX349803B (es) * 2011-02-11 2017-08-14 Ctc Bio Inc Preparación farmacéutica de película que contiene sildenafil en su forma de base libre y método para producir dicha preparación.
KR101418406B1 (ko) * 2011-08-24 2014-07-10 한미약품 주식회사 실데나필 유리 염기를 포함하는 구강 붕해정
MX366768B (es) * 2011-12-08 2019-07-17 Laboratorios Liomont S A De C V Tableta orodispersable de sildenafil y metodo para preparar la misma.
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN114246835A (zh) * 2022-01-05 2022-03-29 河北龙海药业有限公司 一种枸橼酸西地那非口腔崩解片的制备方法
CN121925251A (zh) * 2023-08-30 2026-04-24 陶氏环球技术有限责任公司 喷雾干燥的赋形剂共混物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DE19532142A1 (de) * 1995-08-31 1997-03-06 Siemens Ag Verfahren und Vorrichtung zur Regelung eines vierdimensionalen Vektors einer Strecke mittels eines wertediskreten Stellgliedes mit begrenzter Schaltfrequenz
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
IL132993A0 (en) * 1997-05-29 2001-03-19 Mochida Pharm Co Ltd Therapeutic agent for erection failure
TW542719B (en) * 1998-02-23 2003-07-21 Pfizer Res & Dev Method of treating impotence due to spinal cord injury
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
EP1171134A4 (fr) * 1999-03-16 2005-01-05 Pentech Pharmaceuticals Inc Liberation controlee de sildenafil administre par voie sublinguale ou orale

Also Published As

Publication number Publication date
HRP990144A2 (en) 2000-02-29
BG103396A (bg) 2000-01-31
GT199900061A (es) 2000-10-14
AP9901534A0 (en) 1999-06-30
AU2812699A (en) 1999-11-25
PA8472901A1 (es) 2000-09-29
AU753478B2 (en) 2002-10-17
DZ2786A1 (fr) 2003-12-01
EP0960621A2 (fr) 1999-12-01
IS5046A (is) 1999-11-16
CA2272042A1 (fr) 1999-11-15
TR199901077A3 (tr) 1999-12-21
NZ335772A (en) 2000-12-22
PE20000546A1 (es) 2000-07-07
BR9902086A (pt) 2000-05-02
YU21999A (sh) 2002-03-18
KR19990088249A (ko) 1999-12-27
TR199901077A2 (en) 1999-12-21
MA26629A1 (fr) 2004-12-20
OA11040A (en) 2003-01-01
SK61599A3 (en) 2000-12-11
US20020002172A1 (en) 2002-01-03
EA199900373A2 (ru) 1999-12-29
CO5060503A1 (es) 2001-07-30
ZA993338B (en) 2000-11-14
SG79255A1 (en) 2001-03-20
EP0960621A3 (fr) 2000-01-05
JPH11349483A (ja) 1999-12-21
HN1999000066A (es) 1999-09-29
NO992339D0 (no) 1999-05-14
PL333118A1 (en) 1999-11-22
HU9901606D0 (en) 1999-07-28
EA199900373A3 (ru) 2000-08-28
CN1251758A (zh) 2000-05-03
AR016481A1 (es) 2001-07-04
ID23299A (id) 2000-04-05
HUP9901606A2 (en) 2002-09-28
EA002830B1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
ID23299A (id) Formulasi-formulasi farmasi
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20004240L (no) Formuleringer
ID27415A (id) Komposisi farmaseutik
ATE224703T1 (de) Brauseformulierungen
NO20005913D0 (no) Legemiddelsammensetning
PT1130966E (pt) Formulacoes antiparasitarias
NO20012915L (no) Ny farmasöytisk formulering
ID24654A (id) Formulasi farmasi omeprazola
ID29262A (id) Komposisi farmasi
DK1466615T3 (da) Farmaceutisk præparat
NO20015670L (no) Forbedrede farmasöytiske formuleringer
ID27201A (id) Komposisi farmasi
IS6398A (is) Lyfjablöndur
ID30032A (id) Formulasi farmasi
ID16781A (id) Formulasi-formulasi farmasi
EE9900440A (et) Farmatseutilised kompositsioonid
EE200000330A (et) Farmatseutilised kompositsioonid
EP1124557A4 (fr) Composition pharmaceutique
IS2200B (is) Lyfjasamsetningar
EP1142589A4 (fr) Preparations medicinales
NO994436D0 (no) Farmasöytiske sammensetninger
SE9803952D0 (sv) Pharmaceutical formulation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application